A SIMPLE OUTPATIENT TREATMENT WITH ORAL IFOSFAMIDE AND ORAL ETOPOSIDE FOR PATIENTS WITH SMALL CELL LUNG-CANCER (SCLC)

被引：33

作者：

CERNY, T

LIND, M

THATCHER, N

SWINDELL, R

STOUT, R

机构：

[1] CHRISTIE HOSP & HOLT RADIUM INST,CTR CANC RES,DEPT MED ONCOL,MANCHESTER M20 9BX,LANCS,ENGLAND

[2] CHRISTIE HOSP & HOLT RADIUM INST,DEPT RADIOTHERAPY,MANCHESTER M20 9BX,LANCS,ENGLAND

[3] CHRISTIE HOSP & HOLT RADIUM INST,DEPT MED STAT,MANCHESTER M20 9BX,LANCS,ENGLAND

来源：

关键词：

D O I：

10.1038/bjc.1989.265

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：258 / 261

页数：4

共 22 条

[1] IFOSFAMIDE - PHARMACOLOGY, SAFETY AND THERAPEUTIC POTENTIAL
BRADE, WP
HERDRICH, K
VARINI, M
[J]. CANCER TREATMENT REVIEWS, 1985, 12 (01) : 1 - 47
[2] STUDIES ON THE UROTOXICITY OF OXAZAPHOSPHORINE CYTOSTATICS AND ITS PREVENTION .3. PROFILE OF ACTION OF SODIUM 2-MERCAPTOETHANE SULFONATE (MESNA)
BROCK, N
POHL, J
STEKAR, J
SCHEEF, W
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (12): : 1377 - &
[3] CAVALLI F, 1978, CANCER TREAT REP, V62, P473
[4] PRETREATMENT PROGNOSTIC FACTORS AND SCORING SYSTEM IN 407 SMALL-CELL LUNG-CANCER PATIENTS
CERNY, T
BLAIR, V
ANDERSON, H
BRAMWELL, V
THATCHER, N
[J]. INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (02) : 146 - 149
[5] CERNY T, 1987, BRIT J CANCER, V56, P237
[6] CERNY T, 1986, CANCER CHEMOTH PHARM, V18, P261
[7] COMIS RL, 1986, SEMIN ONCOL, V13, P75
[8] GRAYDONHARKER W, 1986, CANCER RES, V46, P2369
[9] JOSS RA, 1987, CANCER CHEMOTHERAPY, P146
[10] THERAPY OF SMALL CELL LUNG-CANCER - ANYTHING NEW
KLASTERSKY, J
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02): : 107 - 112